ES2089194T3 - Nuevo uso de linomide. - Google Patents

Nuevo uso de linomide.

Info

Publication number
ES2089194T3
ES2089194T3 ES91905238T ES91905238T ES2089194T3 ES 2089194 T3 ES2089194 T3 ES 2089194T3 ES 91905238 T ES91905238 T ES 91905238T ES 91905238 T ES91905238 T ES 91905238T ES 2089194 T3 ES2089194 T3 ES 2089194T3
Authority
ES
Spain
Prior art keywords
linomide
new use
treatment
invention concerns
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905238T
Other languages
English (en)
Inventor
Bo Nilsson
Terje Kalland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2089194T3 publication Critical patent/ES2089194T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE AL USO DE LINOMIDE (R) O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLE PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE INFECCIONES RETROVIRICAS. ESPECIFICAMENTE EL INVENTO CONCIERNE AL TRATAMIENTO DE LAS INFECCIONES DE VIH
ES91905238T 1990-02-22 1991-02-21 Nuevo uso de linomide. Expired - Lifetime ES2089194T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use

Publications (1)

Publication Number Publication Date
ES2089194T3 true ES2089194T3 (es) 1996-10-01

Family

ID=20378638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905238T Expired - Lifetime ES2089194T3 (es) 1990-02-22 1991-02-21 Nuevo uso de linomide.

Country Status (11)

Country Link
EP (1) EP0516725B1 (es)
JP (1) JPH05503532A (es)
AT (1) ATE139442T1 (es)
AU (1) AU641002B2 (es)
CA (1) CA2076650C (es)
DE (1) DE69120396T2 (es)
DK (1) DK0516725T3 (es)
ES (1) ES2089194T3 (es)
GR (1) GR3020798T3 (es)
SE (1) SE9000624D0 (es)
WO (1) WO1991012804A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
IL129871A (en) 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
WO1999030711A1 (fr) * 1997-12-15 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Medicaments augmentant les cellules nkt
JP4523281B2 (ja) * 2002-01-17 2010-08-11 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害薬として有用なヒドロキシナフチリジノンカルボキサミド類
AU2004304770B2 (en) 2003-12-08 2010-05-06 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties by small oligonucleotide-based compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
DE69120396D1 (de) 1996-07-25
EP0516725A1 (en) 1992-12-09
AU7446691A (en) 1991-09-18
JPH05503532A (ja) 1993-06-10
ATE139442T1 (de) 1996-07-15
DK0516725T3 (da) 1996-09-09
CA2076650A1 (en) 1991-08-23
GR3020798T3 (en) 1996-11-30
DE69120396T2 (de) 1997-01-30
CA2076650C (en) 1998-04-28
AU641002B2 (en) 1993-09-09
EP0516725B1 (en) 1996-06-19
SE9000624D0 (sv) 1990-02-22
WO1991012804A1 (en) 1991-09-05

Similar Documents

Publication Publication Date Title
ES2134764T3 (es) Inhibidores de hiv proteasa.
SE8704298D0 (sv) Compounds for use in therapy
SE9903544D0 (sv) Novel compounds
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
AU7619291A (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DK77981A (da) Cephalosporinderivater samt fremgangsmaade til fremstilling deraf
ES2089194T3 (es) Nuevo uso de linomide.
DK0393424T3 (da) Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
MX13723A (es) Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
ES2087291T3 (es) Nuevo uso de bambuterol.
ES2098325T3 (es) Tratamiento de cataratas con compuestos de prostaciclina.
BR9105405A (pt) Derivados de cefalosporina,preparado farmaceutico,processo para a preparacao de compostos e uso
MX9202948A (es) Uso de atipamezol.
ATE75746T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
SE9000288D0 (sv) New use
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
NO901418L (no) Cefalosporinderivater og deres fremstilling.
IL89658A0 (en) Aqueous pharmaceutical composition for impeding the deterioration of patients carrying the aids virus

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 516725

Country of ref document: ES

FG2A Definitive protection

Ref document number: 516725

Country of ref document: ES